Cargando…

Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI

INTRODUCTION: Obtaining an adequate number of high-quality oocytes is a major challenge in controlled ovarian hyperstimulation (COH). To date, a range of hormonal and clinical parameters have been used to optimize COH but none have significant predictive value. This variability could be due to the g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boudjenah, Radia, Molina-Gomes, Denise, Torre, Antoine, Bergere, Marianne, Bailly, Marc, Boitrelle, Florence, Taieb, Stéphane, Wainer, Robert, Benahmed, Mohamed, de Mazancourt, Philippe, Selva, Jacqueline, Vialard, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372493/ https://www.ncbi.nlm.nih.gov/pubmed/22701696 http://dx.doi.org/10.1371/journal.pone.0038700

Ejemplares similares

Associations between Individual and Combined Polymorphisms of the TNF and VEGF Genes and the Embryo Implantation Rate in Patients Undergoing In Vitro Fertilization (IVF) Programs
por: Boudjenah, Radia, et al.
Publicado: (2014)

SAT-295 Low Dose rFSH Prior to HCG-rFSH Therapy in Kallmann Syndrome
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2019)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

To be or not to be [fertile], that is the question
por: Swierkowski-Blanchard, N., et al.
Publicado: (2016)

Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study
por: Barbosa, Caio Parente, et al.
Publicado: (2014)

The nature of human sperm head vacuoles: a systematic literature review
por: Boitrelle, Florence, et al.
Publicado: (2013)

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone
por: Canosa, Stefano, et al.
Publicado: (2022)

RHOXF2 gene, a new candidate gene for spermatogenesis failure
por: Frainais, Christophe, et al.
Publicado: (2014)

Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis
por: Bordewijk, E M, et al.
Publicado: (2019)

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
por: Papaleo, Enrico, et al.
Publicado: (2014)

Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF
por: Gomaa, Hala, et al.
Publicado: (2012)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016)

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
por: Leader, Arthur, et al.
Publicado: (2013)

Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist
por: Chapon, Rita de Cassia Borges, et al.
Publicado: (2021)

Identity suffering in infertile men
por: Jaoul, Monique, et al.
Publicado: (2014)

FSH versus AMH: age-related relevance to ICSI results
por: Salama, Sameh, et al.
Publicado: (2021)

Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing
por: Bøtkjær, Jane Alrø, et al.
Publicado: (2022)

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
por: Yovich, John L, et al.
Publicado: (2016)

FSH Beyond Fertility
por: Lizneva, Daria, et al.
Publicado: (2019)

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System
por: Beresniak, Ariel, et al.
Publicado: (2023)

The role of FSH to AMH ratio in poor prognosis patients undergoing ICSI cycle
por: Gözükara, İlay, et al.
Publicado: (2022)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count
por: La Marca, Antonio, et al.
Publicado: (2013)

The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles
por: Hu, Linli, et al.
Publicado: (2020)

Comparing clomiphen citrate plus HMG with clomiphen citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: A prospective randomized study
por: Azargoon, Azam, et al.
Publicado: (2013)

A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART
por: Siristatidis, Charalampos, et al.
Publicado: (2021)

IVF or ICSI for fertility preservation?
por: Aggarwal, Bhorika, et al.
Publicado: (2021)

Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation
por: Drakakis, Peter, et al.
Publicado: (2009)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017)

Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles
por: Vitthala, Srisailesh, et al.
Publicado: (2012)

Analysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patients
por: Shahrokh Tehraninezhad, Ensieh, et al.
Publicado: (2016)

Is intracouple assisted reproductive technology an option for men with large-headed spermatozoa? A literature review and a decision guide proposal
por: Guthauser, Bruno, et al.
Publicado: (2016)

Combinational approach of retrospective clinical evidence and transcriptomics highlight AMH superiority to FSH, as successful ICSI outcome predictor
por: Kastora, Stavroula Lila, et al.
Publicado: (2020)

Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders
por: Leijdekkers, Jori A, et al.
Publicado: (2019)

Improving Implantation Rate in 2nd ICSI Cycle through Ovarian Stimulation with FSH and LH in GNRH Antagonist Regimen
por: Setti, Amanda Souza, et al.
Publicado: (2021)

Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
por: Olsson, Håkan, et al.
Publicado: (2015)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?
por: Bentov, Yaakov, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t7i1vmvkr8230k61eq1j99roq4